Quest Diagnostics Incorporated
$250.27
+4.65 · +1.89% today
Market open · updated 12:45:29 PM ET
- High
- $249.53 11:00 AM
- Low
- $244.43 1:00 PM
Against the S&P 500 Price change through Oct 28, 2026
DGX+41.54%
S&P 500+13.26%
DGX+37.77%
S&P 500+12.41%
DGX+92.37%
S&P 500+88.06%
DGX+68.43%
S&P 500+68.51%
Key numbers
- Previous close
- $245.62
- Open
- $248.58
- Day's range
- $246.59 – $251.33
- 52-week range
- $171.18 – $251.33
- Volume
- 294,223
- Average volume
- 1.0 million
- Market value
- $27.6 billion
- Price to earnings
- 24.1last 12 months
- Earnings per share
- $10.26last 12 months
- Beta
- 0.54moves less than the market
- Dividend
- $3.38 a year · 1.38%
- 50-day average
- $238.10
- 200-day average
- $211.46
Analyst price targets and the full financials are in the terminal.
Who Quest Diagnostics competes with From our value chain
Quest Diagnostics in the news
No desk stories on DGX yet. When we write about it, the story leads this list.
- HeadlineWhy Quest Diagnostics (DGX) is a Top Value Stock for the Long-TermZacks Investment Research · October 27, 2026 at 10:41 AM ET
- HeadlineQuest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer'sSeeking Alpha · October 26, 2026 at 10:53 PM ET
- HeadlineLab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breachTechCrunch · October 23, 2026 at 11:00 AM ET
- HeadlineWhy Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-TermZacks Investment Research · October 23, 2026 at 10:50 AM ET
- HeadlineDGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-MarketZacks Investment Research · October 22, 2026 at 3:21 PM ET
- HeadlineWhat Quest Diagnostics (DGX) Said on Its Q3 Earnings CallMarketBeat · October 22, 2026 at 2:06 PM ET
- HeadlineQuest Diagnostics: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · October 22, 2026 at 2:04 PM ET
- HeadlineQuest Diagnostics Incorporated (DGX) Q3 2026 Earnings Call TranscriptSeeking Alpha · October 22, 2026 at 1:27 PM ET
Congress trades in DGX
4 purchases and 3 sales in the latest 7 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Julie JohnsonHouse · D-Texas | Purchase | $1,001 - $15,000 | Oct 30, 2025 | Aug 6, 2026 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Oct 30, 2025 | Aug 6, 2026 |
| Alan ArmstrongSenate · R-Oklahoma | Purchase | $1,001 - $15,000 | Mar 27, 2026 | Jul 22, 2026 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Nov 3, 2025 | Dec 12, 2025 |
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Jan 24, 2025 | Feb 12, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Nov 15, 2024 | Dec 6, 2024 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Quest Diagnostics
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 57,000
- Headquarters
- Secaucus, New Jersey
- Website
- questdiagnostics.com
- Listed
- Dec 17, 1996
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.